The UK parliament enacted The Medicines and Medical Devices Act post Brexit for patient safety concerning the use of medical devices and drugs.
Verdict has conducted a poll to analyse whether medical devices in the UK will continue to have a high degree of safety until all new post-Brexit regulations come into effect by 2023.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Analysis of the poll results shows that a majority 41% of the respondents do not know whether the existing safety standards are adequate for medical devices in the UK until all new post-Brexit regulations come into effect by 2023.
Further 36% of the respondents believe the existing UK standards of safety are sufficient, while 23% believe that they are inadequate.
The analysis is based on 213 responses received from the readers of Medical Device Network, a Verdict network site, between 07 December 2020 and 09 March 2021.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataImplications of Brexit on the medical devices industry in the UK
Brexit has elevated the need to empower the UK Medicines and Healthcare products Regulatory Agency (MHRA) for better regulation of medical devices in the UK, as the country withdrew from the European Medicines Agency, and other drug and medical device regulatory authorities.
The UK plans to appoint a Patient Safety Commissioner (PSC) to administer healthcare in the nation, implement the regulations, and promote patient safety related to medical devices. The PSC will remain neutral and place patient safety among its top priorities. It will be funded by the Department of Health and Social Care and appointed by the Secretary of State.
The National Health Service will also establish a Healthcare Safety Investigations Branch to investigate patient safety incidents.
